Back to 
Woodline Partners LP
Woodline Partners LP
COAG
1 quarters
Position history for Woodline Partners LP's holdings in Hemab Therapeutics Holdings, Inc.
Yes. Woodline Partners holds 150,040 shares of COAG (Hemab Therapeutics Holdings), worth $5.5M, as of its Q2 2026 13F filing.
Current Value
$5.5M
Current Shares
150,040
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of COAG: RA Capital Management, L.P., FMR LLC, Capital International Investors, Avoro Capital Advisors LLC, JPMorgan Chase & Co.